U.S. Paper and Forestry Products Stock News

NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

What Mirum Pharmaceuticals (MIRM)'s Volixibat PSC Trial Win and $600M Notes Deal Means For Shareholders

Earlier in May 2026, Mirum Pharmaceuticals completed a US$600,000,000 zero-coupon senior unsecured convertible note offering due June 1, 2032, while also reporting a quarterly net loss of US$790.16 million and raising 2026 net product sales guidance to US$660 million–US$680 million. The company also reported that its VISTAS Phase 2b trial of volixibat in primary sclerosing cholangitis met its primary endpoint, reinforcing the potential for the drug to address an area with no approved PSC...
NasdaqGS:INTA
NasdaqGS:INTASoftware

Intapp (INTA) Is Down 11.9% After Mixed Q3 Results And Major Buyback, Shelf Registration Moves

Earlier in May 2026, Intapp reported fiscal third-quarter results showing US$146.04 million in revenue and a higher net loss of US$15.5 million, alongside completing a US$100.03 million buyback and filing a shelf registration for over 23 million common shares and multiple other securities. The earnings release also highlighted strong SaaS and cloud ARR growth, while a new DealCloud win with Republic Partners underscored Intapp’s traction with financial and professional services clients...
NasdaqGS:IPGP
NasdaqGS:IPGPElectronic

Is Mixed Q1 Results and China Trade Optimism Altering The Investment Case For IPG Photonics (IPGP)?

In early May 2026, IPG Photonics reported first-quarter 2026 sales of US$265.5 million and net income of US$1.58 million, issued second-quarter revenue guidance of US$260 million to US$290 million, and hosted a Laser Applications & Automation Seminar while granting multiple director equity awards. At the same time, investor sentiment around IPG Photonics was heavily influenced by hopes for easing U.S.-China chip export restrictions and rare earth supply risks, alongside elevated valuation...
NYSE:WTM
NYSE:WTMInsurance

Does Refinancing Into 7.39% Notes and Funding a Dividend Recast White Mountains Insurance Group’s (WTM) Capital Playbook?

White Mountains Insurance Group’s subsidiary HG Global Ltd. has completed a US$200 million private placement of 7.39% fixed-rate senior secured notes due 2036, using the proceeds to refinance an existing US$150 million term loan, pay related fees, and fund a dividend to White Mountains and other equity holders. By replacing floating-rate debt that carried a 9.93% interest cost with longer-term fixed-rate notes, the company enhances interest expense visibility while simultaneously returning...
NYSE:ARMK
NYSE:ARMKHospitality

Aramark (ARMK) Valuation Check After Earnings Beat And AI Data Center Expansion

Aramark (ARMK) stock is in focus after the company beat quarterly revenue and adjusted EPS estimates, raised its fiscal 2026 organic growth guidance, and highlighted new client wins alongside expansion into hyperscale AI data center services. See our latest analysis for Aramark. That upbeat earnings report, new university partnership, and expansion into hyperscale AI data center services have coincided with strong momentum, with a 7 day share price return of 19.12% and a 1 year total...
NYSE:STNG
NYSE:STNGOil and Gas

The Bull Case For Scorpio Tankers (STNG) Could Change Following Profit Surge And Aggressive Buybacks – Learn Why

Earlier in May, Scorpio Tankers Inc. reported a sharp year-on-year jump in first-quarter net income to US$216.26 million and affirmed a quarterly dividend of US$0.45 per share, while also advancing its US$830.5 million buyback program, completing the repurchase of 14,073,518 shares since February 2023. Alongside these results, Scorpio raised US$220.5 million through convertible notes due 2031 and filed a US$27.13 million shelf registration for ESOP-related common stock, underscoring an...
NYSE:TREX
NYSE:TREXBuilding

Is Trex (TREX) Using Buybacks And Steady Guidance To Quietly Redefine Its Margin Story?

In early May 2026, Trex Company, Inc. reported first-quarter 2026 results showing modest year-on-year increases in sales and net income, reaffirmed its full-year 2026 net sales outlook of US$1.19 billion to US$1.23 billion, issued second-quarter revenue guidance of US$388 million to US$403 million, completed a US$265.78 million share repurchase program, and appointed long-time executive Zachary C. Lauer as Chief Operations Officer following a CEO transition. Together, the earnings growth,...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Is Analyst Optimism And Wellington’s Stake Reshaping The Investment Case For Omnicell (OMCL)?

Earlier in May 2026, Omnicell, Inc. drew investor attention as analysts responded to its fiscal Q1 2026 results with updated research views that emphasized demand trends and product innovation across its medication management portfolio. In parallel, Wellington Management disclosed a Schedule 13G filing showing a meaningful beneficial stake in Omnicell, underscoring institutional interest in the company’s healthcare automation franchise. With analysts emphasizing Omnicell’s product innovation...
NYSE:PRM
NYSE:PRMChemicals

Assessing Perimeter Solutions (PRM) Valuation After Strong Q1 2026 Results And Rapid Share Price Gains

Perimeter Solutions (PRM) has drawn fresh attention after first quarter 2026 results showed sales of US$125.07 million and net income of US$72.94 million, along with a renewed emphasis on acquisitions and disciplined capital deployment. See our latest analysis for Perimeter Solutions. The earnings and acquisition comments have landed after a strong run in the stock, with a 30 day share price return of 19.53% and a 1 year total shareholder return of 181.13%, suggesting that momentum has been...
NYSE:TUYA
NYSE:TUYASoftware

Assessing Tuya (TUYA) Valuation After Strong Q1 2026 AI Growth And New Aura Robot Launch

Tuya (TUYA) is back in focus after its first quarter 2026 report highlighted higher sales, stronger profitability, and fresh AI driven products, including the Aura pet companion robot launched at CES. See our latest analysis for Tuya. The stock has been choppy, with a 7 day share price return down 10.16% and a 30 day share price return down 11.24%. However, a 3 year total shareholder return of 35.78% points to earlier momentum that has not fully carried through recently. If Tuya’s AI push has...
NYSE:APLE
NYSE:APLEHotel and Resort REITs

How Investors Are Reacting To Apple Hospitality REIT (APLE) Guidance Hike And New Marriott Deals

Apple Hospitality REIT, Inc. reported past first-quarter 2026 results showing year-over-year revenue growth to US$337.74 million but slightly lower net income of US$27.70 million, while also entering forward-purchase contracts for new Marriott-branded hotels in Anchorage and Las Vegas. The company also raised its full-year 2026 net income guidance midpoint by US$9 million, signaling higher expected profitability despite softer quarterly earnings. With Apple Hospitality REIT lifting its 2026...
NasdaqCM:NEXT
NasdaqCM:NEXTOil and Gas

Is NextDecade's (NEXT) New Equity Shelf a Signal on Its Long-Term Financing Playbook?

In May 2026, NextDecade Corporation filed a shelf registration to potentially issue 19,730,742 shares of common stock, with an aggregate anticipated value of approximately US$167.71 million, providing flexibility to raise equity capital over time. This filing highlights management’s willingness to use additional equity as a funding lever, a decision that may influence views on dilution, balance sheet strength and future project financing options. We’ll now examine how this potential...
NYSE:EMN
NYSE:EMNChemicals

Assessing Eastman Chemical (EMN) Valuation After Recent Share Price Weakness

Recent performance snapshot Eastman Chemical (EMN) has been under pressure recently, with the stock down about 1% over the past day, 4% over the past week, and 3% over the past month. Over the past 3 months, the share price is down about 10%, and the 1 year total return shows a decline of 9%, even though the year to date return is up around 11%. See our latest analysis for Eastman Chemical. At a share price of US$71.58, Eastman Chemical’s recent declines in shorter term share price returns,...
NasdaqGS:IBKR
NasdaqGS:IBKRCapital Markets

Unified Prediction Markets Interface Might Change The Case For Investing In Interactive Brokers Group (IBKR)

Interactive Brokers Group recently launched a unified interface that lets eligible clients trade prediction market contracts across Kalshi, CME Group, and ForecastEx from a single platform, fully integrated alongside traditional assets such as stocks, options, futures, forex, crypto, and bonds. This move introduces a consolidated way to access event-based contracts on elections, climate events, and economic indicators, potentially broadening how investors hedge event risk and express views...
NasdaqGS:LINE
NasdaqGS:LINEIndustrial REITs

Assessing Lineage (LINE) Valuation After Q1 Loss And Modest Undervaluation Signal

Q1 earnings shift Lineage’s results into the red Lineage (LINE) reported first quarter 2026 earnings that kept sales broadly steady at US$1,297 million, while results moved from a profit a year ago to a net loss of US$46 million. See our latest analysis for Lineage. The latest share price of US$38.45 leaves Lineage with an 8.6% year to date share price gain, even though the 1 year total shareholder return declined 15%. This suggests that recent momentum has improved, but longer term sentiment...
NYSE:CNK
NYSE:CNKEntertainment

A Look At Cinemark Holdings (CNK) Valuation After Its Recent Share Price Pullback

Why Cinemark Holdings Stock Is Drawing Attention Now Cinemark Holdings (CNK) is on investors’ radar after a recent pullback, with the stock down about 13% over the past month even as its past 3 months return remains positive. See our latest analysis for Cinemark Holdings. At the current share price of $25.96, Cinemark’s recent pullback includes a 1-day share price return of down 1.52% and a 30-day share price return of down 13.5%. Its year to date share price return of 10.33% contrasts with a...
NYSE:BCC
NYSE:BCCTrade Distributors

What Boise Cascade (BCC)'s Buyback Completion and Insider Sales Mean For Shareholders

In its recent updates, Boise Cascade reported first-quarter 2026 sales of US$1,498.61 million and net income of US$17.84 million, completed a US$160.89 million share repurchase program, and confirmed the past election of Jeff Strom to its board for a term ending in 2027. Alongside these results, insider selling by senior vice president and general counsel Jill Twedt and the completion of a sizeable buyback highlight how capital allocation and executive share ownership are evolving at Boise...
NasdaqGS:FIBK
NasdaqGS:FIBKBanks

Does CEO Reuter’s Interim COO Role Reshape Management Risk At First Interstate BancSystem (FIBK)?

First Interstate BancSystem recently terminated Kristina Robbins’ role as Executive Vice President and Chief Operating Officer without cause, effective May 11, 2026, and reassigned her to a temporary Executive Advisor position supporting CEO James Reuter while he assumes interim COO responsibilities. This reshaping of the senior leadership team concentrates operational control with the CEO during the search for a new COO, raising questions about how execution and oversight will be managed in...
NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

A Look At Agilysys (AGYS) Valuation As AI-Powered Hospitality Solutions Gain Customer Traction

Agilysys (AGYS) stock is back in focus after the company used its INSPIRE 2026 conference to showcase more than 30 AI-powered features that customers report are improving efficiency, guest engagement, and revenue performance. See our latest analysis for Agilysys. Despite the recent INSPIRE 2026 product announcements and upcoming earnings update, Agilysys' share price has fallen 41.7% year to date and the 1 year total shareholder return is down 18.9%. However, the 5 year total shareholder...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

A Look At Nurix Therapeutics (NRIX) Valuation After New NX-5948 Data And EHA Congress Selection

Nurix Therapeutics (NRIX) is back in focus after reporting new preclinical and Phase 1 data for its BTK degrader NX-5948, and after securing an oral presentation slot at the European Hematology Association Congress. See our latest analysis for Nurix Therapeutics. Despite the recent NX-5948 data and the upcoming European Hematology Association presentation, Nurix Therapeutics’ share price has eased over the past month, with a 30 day share price return of 9.45% down, even as the 1 year total...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

How Investors Are Reacting To Golar LNG (GLNG) Mounting Cash Burn And Dilution Risks

In recent commentary, investors have focused on Golar LNG’s multi-year 2.7% annual sales decline and continued cash burn, which raise questions about its financial resilience. An important concern is the possibility that these pressures could eventually require new fundraising, potentially diluting existing shareholders and challenging confidence in the company’s long-term plan. Next, we’ll examine how these worries about cash burn and potential fundraising intersect with Golar LNG’s...
NYSE:EQR
NYSE:EQRResidential REITs

Is It Time To Reassess Equity Residential (EQR) After Recent Share Price Swings?

If you are wondering whether Equity Residential at around US$63.88 is offering value or just treading water, the stock’s recent performance gives you a useful starting point. The share price is up 3.0% year to date and 1.9% over the past month, although it is down 3.5% over the last week and down 6.5% over the past year, which can change how the market is thinking about risk and opportunity. Recent coverage has focused on how Equity Residential fits into broader conversations about listed...
NasdaqGS:VCTR
NasdaqGS:VCTRCapital Markets

What Victory Capital Holdings (VCTR)'s Q1 2026 Earnings Beat and AUM Scale Means For Shareholders

Victory Capital Holdings, Inc. recently reported first-quarter 2026 results, with revenue of US$387.99 million and net income of US$112.14 million, and declared a quarterly dividend of US$0.50 per share payable on June 25, 2026. The firm also disclosed Total Assets Under Management of US$329.10 billion as of April 30, 2026 and a 3.8% passive stake held by Capital World Investors, underscoring both business scale and institutional investor interest. We’ll now examine how Victory Capital’s...
NYSE:CC
NYSE:CCChemicals

Chemours (CC) Is Down 8.4% After Issuing 2026 Profit Guidance Amid Q1 Net Loss

The Chemours Company recently reported first quarter 2026 results, with sales of US$1,381 million and a net loss of US$29 million, while also affirming a quarterly cash dividend of US$0.0875 per share. At the same time, Chemours issued new guidance calling for sequential net sales growth in the second quarter of 2026 and full‑year 2026 net income attributable to the company between US$165 million and US$225 million, framing a clearer profitability path after a period of losses. Now we’ll...